NUS, Agilent, and NUH Launch New Translational R&D Hub to Boost Clinical Diagnostics
Last agilent technologies, inc earnings: 2/18 04:05 pm
Check Earnings Report
US:NYSE Investor Relations: investor.agilent.com
S$38 million research facility aims to be a premier, global, one-stop hub for research and translation to clinical testing through biochemical innovation and techniques SINGAPORE--(BUSINESS WIRE)--The National University of Singapore (NUS), Agilent Technologies, a global leader in life sciences, diagnostics, and applied chemical markets, and National University Hospital (NUH), have established Singapore’s first integrated translational R&D hub that leverages biochemical innovation and research data analytics to develop new methods of translating clinical research into clinical diagnostics.The NUS-Agilent Hub for Translation & Capture (NUS-Agilent Hub) was officially launched by Associate Professor Benjamin Ong, Director of Medical Services of the Ministry of Health, at the opening ceremony held in NUS today. The research hub, which comprises laboratories located in NUS and NUH, provides 1,000 square metres of research space to facilitate multidisciplinary collaborations among scien
[Read more]
| Impact snapshot | Event time: | A | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last price | ||
| VWAP | ||
|
High:
|
Max up |
High:
|
|
Low:
|
Max down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event Day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance Since Event
Time and Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
SIGN UP TODAY
Opt-in for
A alerts
A alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
A alerts
High impacting Agilent Technologies, Inc news events
Weekly update
A roundup of the hottest topics
A
News
- Oxford BioDynamics signs supply and resale agreement with Agilent Technologies, and launches EpiSwitch® Explorer Array Kit for R&D useBusiness Wire
- Agilent Awards Octagon Therapeutics with a Golden Ticket at LabCentralBusiness Wire
- Agilent Technologies, Inc. (<a href="https://www.marketbeat.com/stocks/NYSE/A/price-target/">NYSE: A</a>) was upgraded by analysts at Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell from a "neutral" rating to a "bMarketBeat
- Agilent Technologies, Inc. (<a href="https://www.marketbeat.com/stocks/NYSE/A/price-target/">NYSE: A</a>) was upgraded by analysts at Redburn Partners from a "neutral" rating to a "buy" rating.MarketBeat
- Agilent Technologies, Inc. (<a href="https://www.marketbeat.com/stocks/NYSE/A/price-target/">NYSE: A</a>) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.MarketBeat
- More
A
SEC Filings
- 4/1/21 - Form 4
- 3/22/21 - Form 4
- 3/22/21 - Form 4
- A's page on the SEC website
- More